Resultados de búsqueda - (((((esteoen OR wttestoeaeveemmmn) OR esteeem) OR steroids) OR esteban) OR (est OR esteea)) point*

Limitar resultados
  1. 1

    Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease por Gutiérrez Aguirre, César Homero, Cantú Rodríguez, Olga Graciela, Borjas Almaguer, Omar David, González Llano, Óscar, Jaime Pérez, José Carlos, Solano Genesta, M., Gómez Guijosa, Miguel Ángel, Mancías Guerra, Consuelo, Tarín Arzaga, Luz del Carmen, Gómez Almaguer, David

    Publicado 2012
    “…At Day +90 evaluation, 7 (50%) patients had partial remission, 4 (28%) had complete remission; 3 (21%) had relapsed chronic graft-versus-host disease and one patient did not reach the evaluation time point. So far, 5 patients have reached the Day +365 follow-up evaluation; 2 (40%) had partial remission, 2 had complete remission and one experienced chronic graft-versus-host disease progression. …”
    Enlace del recurso
    Artículo
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

Herramientas de búsqueda: